Tysabri: What the New FDA Approval Means to You Broadcast on: June 22, 2006 Listen to the replay! Tysabri has been approved by the FDA for re-release for use in patients with relapsing-remitting MS. What does this mean for you? Experts will be discussing the recall and the re-approval, the benefits and safety of the drug, the risk management plan to be put into place at re-launch, and other information you need to know about this medication. One man’s Tysabri experience This HealthTalk program is sponsored through an educational grant from MS ActiveSource. Howard Rossman, D.O., F.A.C.N. Karen Blitz-Shabbir, M.D. Trevis Gleason, HealthTalk host http://www.healthtalk.com/multiplesclerosis/programs/10_542/index.cfm